More large law firms are spreading the word about their medical cannabis practice capabilities as ethics rule changes and state legislation whittle down the amount of risk involved in providing that guidance. And in Pennsylvania, which is poised to be a center for clinical marijuana research, lawyers expect a major payoff for firms that get involved in the budding industry.
Entering the space still requires firms to weigh the fact that cannabis remains illegal under federal law. For some, malpractice insurance or perceptions of other clients have been a concern. But law firm leaders and practice leaders said those concerns are lessening as the law firm growth opportunities increase.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
